Mark R. Bamforth, Sr.VP, Corporate Operations & Phar at GENZYME CORP (GENZ), sold 19,232 shares at $81.71 ($1.6M) on 2008-08-14, disclosed to the SEC on 2008-08-15.
Open-market sale of $1.6M GENZ by Sr.VP, Corporate Operations & Phar. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDMO | BUY | 2020-03-16 | $104K | — | Filing → |
| CDMO | BUY | 2018-02-20 | $113K | — | Filing → |
| PPHM | BUY | 2017-10-27 | $444K | — | Filing → |